Search clinical trials for: HCQ+AZT

Total 7437 results

Novartis Pharmaceuticals

Completed

Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease

Covid-19

United States
Abbott

Completed

Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation

Irritable Bowel Syndrome

Pakistan
King Hussein Cancer Center

Withdrawn

Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients (MOPHYDA)

COVID-19

Jordan
Queen Mary University of London
University of Oxford; Aga Khan University; University of Bristol; Dow University...

Recruiting

Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

Hepatitis C, Chronic

Pakistan
Chang Gung Memorial Hospital

Completed

Comparison of Choosing Free ALT or Free PMT for Reconstruction With Head and Neck Cancer

Head and Neck Cancer | Reconstructive Surgery

Taiwan
Miguel Monfort Montolio

Not yet recruiting

Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions.

Diagnosis, Dual (Psychiatry)
Miguel Monfort Montolio

Completed

Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and Addictions

Diagnosis, Dual (Psychiatry)
Hospital Israelita Albert Einstein
Hospital do Coracao; Hospital Sirio-Libanes; Brazilian Research In Intensive... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Coronavirus Infections | Pneumonia, Viral

Brazil
Atacama Therapeutics

Active, not recruiting

Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

Hyperhidrosis | Palmar Hyperhidrosis

United States
M.D. Anderson Cancer Center
Syros Pharmaceuticals Inc.

Withdrawn

Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia

United States
National Cancer Institute (NCI)

Terminated

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | Recurrent Lung Small Cell Carcinoma | Stage IIIA Lung Small Cell Carcinoma AJCC v7 | Stage IIIB Lung Small Cell Carcinoma AJCC v7 | Stage IV Lung Small Cell... and other conditions

United States
M.D. Anderson Cancer Center
Kura Oncology, Inc.

Recruiting

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

Refractory Acute Leukemia | Pediatric Relapsed

United States
University of Colorado, Denver

Recruiting

MIRA CONNECT Study (CONNECT)

Pregnancy of Unknown Location (PUL)

United States
Fred Hutchinson Cancer Center
National Institute on Drug Abuse (NIDA); University of Washington; Seattle Children... and other collaborators

Completed

Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use (MERLIN)

HIV Infection

Peru
The University of Hong Kong
The Hong Kong Jockey Club Charities Trust; Hong Kong Young Women's Christian... and other collaborators

Recruiting

Acceptance and Commitment Therapy and Exercise for Older Adults With Chronic Pain

Chronic Pain | Exercise | Older Adults | Acceptance and Commitment Therapy | Psychosocial Intervention | Art

Hong Kong
M.D. Anderson Cancer Center
Qurient Co., Ltd.

Not yet recruiting

Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
M.D. Anderson Cancer Center

Recruiting

A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)

Acute Myeloid Leukemia

United States
Equip, Lesotho
United States Agency for International Development (USAID); Elizabeth Glaser... and other collaborators

Unknown

Outcomes of Differentiated Models of Antiretroviral Treatment (ART) Provision ([MMD])

HIV/AIDS

Lesotho
University of La Laguna

Completed

Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening

Hepatitis C Virus Infection

Spain
Aristotle University Of Thessaloniki

Completed

Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?

Subfertility

Greece
Brian Jonas
National Cancer Institute (NCI); AbbVie

Recruiting

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia

United States
National University of Singapore

Completed

Art Therapy and Music Reminiscence Activity in the Prevention of Cognitive Decline

Mild Cognitive Impairment

Singapore
Azitra Inc.
RCTs

Completed

Safety Study of AZT-04 for Cosmetic Use

Study of Three Doses of AZT-04 for Skin Appearance

United States
Zhebao Wu
Peking Union Medical College Hospital; Beijing Tiantan Hospital; Chinese PLA... and other collaborators

Unknown

Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas

Resistance, Disease | Prolactinoma

China
UnitedHealth Group
University of Pennsylvania; ProHealth Care Associates

Terminated

PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine

Corona Virus Infection | Coronavirus

United States
Midnight Pharma, LLC

Completed

Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia

Chronic Primary Insomnia

United States
UNICEF
Pak Emirates Military Hospital Rawalpindi, Pakistan

Completed

Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression (COVID-19)

Covid19 | Progression

Pakistan
Guang'anmen Hospital of China Academy of Chinese...

Unknown

Efficacy and Safety of Traditional Chinese Medicine (TCM) Comprehensive Therapy in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
University of Nottingham

Recruiting

The Accuracy of Endometrial Ultrasound to Predict Implantation

Infertility, Subfertility

United Kingdom
Masonic Cancer Center, University of Minnesota

Completed

Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD

Graft vs Host Disease

United States
International Antiviral Therapy Evaluation Center
Gilead Sciences

Completed

PREventing Progression of Adipose Tissue Redistribution

HIV Infections

Netherlands
M.D. Anderson Cancer Center

Completed

Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk

Leukemia

United States
National Cancer Institute (NCI)

Completed

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...

United States
Assistance Publique Hopitaux De Marseille

Not yet recruiting

EVALUATION OF THE SAFETY AND EFFICACY OF ADJUSTABLE CONTINENT THERAPY IN CHILDREN WITH SPINAL DYSRAPHISM. (BPUA)

Neurogenic Bladder Due to Spinal Dysraphism

France
Pfizer

Completed

Canadian Pegvisomant Compassionate Study In Acromegalic Patients

Acromegaly

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Genentech, Inc.

Active, not recruiting

AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease Persistence

United States
M.D. Anderson Cancer Center
Celgene

Completed

Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)

Leukemia | AML | MDS

United States
Reproductive Medicine Associates of New Jersey

Completed

Intrauterine Human Chorionic Gonadotropin at the Time of Embryo Transfer

Control Media Only | Study hCG and Media

United States
M.D. Anderson Cancer Center

Recruiting

Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting

Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Acute Bilineal Leukemia | Acute Biphenotypic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute Leukemia

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Genentech, Inc.

Active, not recruiting

Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

Glioma | Astrocytoma | Oligodendroglioma

United States
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia

Leukemia | Chronic Lymphocytic Leukemia

United States
M.D. Anderson Cancer Center
Celgene Corporation

Completed

Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)

Leukemia

United States
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence

Terminated

Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)

Healthy Participants | Rheumatoid Arthritis (RA) Prevention

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome

Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Myelodysplastic Syndrome | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

Leukemia

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States
University of Oklahoma

Completed

Assisted Reproductive Technology (ART) Predictors Study (ART)

Reproductive Aging

United States
Wenzhou Medical University

Recruiting

Comparison of Outcomes With Multifocal Intraocular Lenses (COMIL)

Cataract

China
Abramson Cancer Center of the University of Pennsylvania

Terminated

Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC

Hepatocellular Carcinoma

United States

Search clinical trials for: HCQ+AZT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations